Factors | HR | 95% CI | P value |
---|---|---|---|
Disease-free survival | |||
Sex | 1.55 | 0.39–6.07 | 0.526 |
Age | 2.04 | 0.76–5.48 | 0.157 |
N stage | 3.38 | 1.12–10.28 | 0.029* |
Histological type | 2.89 | 0.88–9.53 | 0.08 |
Treatment | 0.96 | 0.38–2.46 | 0.934 |
Radiation dose | 1.48 | 0.55–3.94 | 0.435 |
Tumor volume | 1.69 | 0.62–4.59 | 0.307 |
Number of CN palsy symptom | 1.92 | 0.69–5.28 | 0.205 |
Initial TN symptom | 0.86 | 0.21–3.59 | 0.85 |
Initial AN symptom | 0.95 | 0.16–5.65 | 0.963 |
Initial ON symptom | 0.41 | 0.02–6.98 | 0.54 |
1-year recovery rate of TN palsy | 3.05 | 0.68–5.28 | 0.205 |
1-year recovery rate of AN palsy | 0.63 | 0.07–5.1 | 0.665 |
1-year recovery rate of ON palsy | 3.91 | 0.24–63.48 | 0.34 |
Overall survival | |||
Sex | 0.87 | 0.16–4.55 | 0.86 |
Age | 3.76 | 1.11–12.79 | 0.034* |
N stage | 4.476 | 1.02–19.73 | 0.048* |
Histological type | 2.98 | 0.78–11.44 | 0.111 |
Treatment | 2.57 | 0.82–8.04 | 0.106 |
Radiation dose | 0.943 | 0.27–3.29 | 0.926 |
Tumor volume | 3.501 | 0.9–13.61 | 0.071 |
Number of CN palsy symptom | 1.162 | 0.28–4.85 | 0.837 |
Initial TN palsy symptom | 0.743 | 0.14–3.94 | 0.728 |
Initial AN palsy symptom | 0.487 | 0.04–5.62 | 0.564 |
Initial ON palsy symptom | 0.286 | 0.01–10.02 | 0.49 |
1-year recovery rate of TN palsy | 2.59 | 0.43–15.56 | 0.295 |
1-year recovery rate of AN palsy | 0.44 | 0.02–10.05 | 0.61 |
1-year recovery rate of ON palsy | 5.39 | 0.26–11.96 | 0.277 |
Distant metastasis-free survival | |||
Sex | 4.36 | 0.44–26.62 | 0.316 |
Age | 1.127 | 0.26–4.94 | 0.874 |
N stage | 6.654 | 1.08–41.06 | 0.041* |
Histological type | 1.719 | 0.29–10.31 | 0.55 |
Treatment | 0.536 | 0.13–2.25 | 0.395 |
Radiation dose | 0.438 | 0.1–1.91 | 0.273 |
Tumor volume | 0.809 | 0.17–3.71 | 0.785 |
Number of CN palsy symptom | 1.39 | 0.24–7.63 | 0.735 |
Initial TN palsy symptom | 1.91 | 0.34–10.78 | 0.464 |
Initial AN palsy symptom | 1.552 | 0.13–18.68 | 0.729 |
Initial ON palsy symptom | 0.798 | 0.22–20.34 | 0.972 |
1-year recovery rate of TN palsy | 0.54 | 0.06–4.47 | 0.567 |
1-year recovery rate of AN palsy | 2.29 | 0.12–43.43 | 0.58 |
1-year recovery rate of ON palsy | 2.68 | 0.23–12.74 | 0.91 |
Locoregional recurrence-free survival | |||
Sex | 0.807 | 0.07–9.74 | 0.866 |
Age | 1.792 | 0.22–14.6 | 0.586 |
N stage | 2.194 | 0.23–20.74 | 0.493 |
Histological type | 2.21 | 0.2–24.47 | 0.518 |
Treatment | 1.211 | 0.16–9.07 | 0.852 |
Radiation dose | 2.794 | 0.38–20.67 | 0.314 |
Tumor volume | 1.96 | 0.21–18.63 | 0.558 |
Number of CN palsy symptom | 4.143 | 0.53–32.21 | 0.174 |
Initial TN palsy symptom | 0.721 | 0.03–16.58 | 0.838 |
Initial AN palsy symptom | 1.476 | 0.12–3.61 | 0.811 |
Initial ON palsy symptom | 1.141 | 0.02–83.88 | 0.952 |
1-year recovery rate of TN palsy | 7.559 | 0.37–153.2 | 0.188 |
1-year recovery rate of AN palsy | – | – | – |
1-year recovery rate of ON palsy | – | – | – |